Tudor Investment Corp ET AL Invests $1.47 Million in Select Medical Holdings Corporation $SEM

Tudor Investment Corp ET AL acquired a new stake in shares of Select Medical Holdings Corporation (NYSE:SEM) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 114,204 shares of the health services provider’s stock, valued at approximately $1,466,000. Tudor Investment Corp ET AL owned 0.09% of Select Medical as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Dimensional Fund Advisors LP raised its holdings in shares of Select Medical by 4.2% in the 3rd quarter. Dimensional Fund Advisors LP now owns 5,197,343 shares of the health services provider’s stock valued at $66,731,000 after acquiring an additional 207,951 shares in the last quarter. State Street Corp increased its position in shares of Select Medical by 1.3% in the second quarter. State Street Corp now owns 4,253,793 shares of the health services provider’s stock worth $64,573,000 after purchasing an additional 55,686 shares during the last quarter. 8 Knots Management LLC purchased a new stake in Select Medical in the second quarter valued at approximately $26,568,000. Bank of America Corp DE lifted its position in Select Medical by 3.4% during the third quarter. Bank of America Corp DE now owns 1,673,302 shares of the health services provider’s stock valued at $21,485,000 after purchasing an additional 54,640 shares during the last quarter. Finally, Millennium Management LLC lifted its position in Select Medical by 407.9% during the third quarter. Millennium Management LLC now owns 1,590,339 shares of the health services provider’s stock valued at $20,420,000 after purchasing an additional 1,277,233 shares during the last quarter. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

Select Medical Trading Up 0.0%

Shares of SEM opened at $16.30 on Monday. Select Medical Holdings Corporation has a fifty-two week low of $11.65 and a fifty-two week high of $18.60. The firm has a market cap of $2.02 billion, a price-to-earnings ratio of 14.17, a PEG ratio of 0.94 and a beta of 1.22. The firm has a 50 day moving average price of $15.74 and a 200-day moving average price of $14.64. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.04 and a current ratio of 1.04.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, February 19th. The health services provider reported $0.16 EPS for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.07). The business had revenue of $1.40 billion during the quarter, compared to analysts’ expectations of $1.36 billion. Select Medical had a return on equity of 7.26% and a net margin of 2.68%.Select Medical’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.18 EPS. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. As a group, equities research analysts forecast that Select Medical Holdings Corporation will post 1.17 earnings per share for the current year.

Select Medical announced that its board has authorized a share repurchase plan on Thursday, February 19th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the health services provider to reacquire up to 49.5% of its shares through open market purchases. Shares buyback plans are usually an indication that the company’s board believes its stock is undervalued.

Select Medical Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, March 12th. Stockholders of record on Monday, March 2nd were paid a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date of this dividend was Monday, March 2nd. Select Medical’s payout ratio is 21.74%.

Wall Street Analysts Forecast Growth

SEM has been the topic of a number of research analyst reports. Zacks Research lowered shares of Select Medical from a “hold” rating to a “strong sell” rating in a report on Thursday, February 26th. Wall Street Zen lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, March 9th. Weiss Ratings raised Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, February 20th. Benchmark lowered Select Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, March 4th. Finally, Royal Bank Of Canada reiterated a “sector perform” rating and issued a $16.50 price objective (down from $19.00) on shares of Select Medical in a report on Tuesday, March 3rd. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $15.63.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.